Propanc Biopharma Inc.
PPCB | NASDAQ
$1.84
-$0.27 (-12.80%)
At close: Oct 30, 2026, 4:00 PM ET
$1.94
+$0.10 (+5.20%)
Pre-market:
Nov 2, 2026, 7:55 AM ET
Fiscal Quarter Period Ending | Q4 2026 Jun 30, 2026 | Q3 2026 Mar 31, 2026 | Q2 2026 Dec 31, 2025 | Q1 2026 Sep 30, 2025 | Q4 2025 Jun 30, 2025 | Q3 2025 Mar 31, 2025 | Q2 2025 Dec 31, 2024 | Q1 2025 Sep 30, 2024 | Q4 2024 Jun 30, 2024 | Q3 2024 Mar 31, 2024 | Q2 2024 Dec 31, 2023 | Q1 2024 Sep 30, 2023 | Q4 2023 Jun 30, 2023 | Q3 2023 Mar 31, 2023 | Q2 2023 Dec 31, 2022 | Q1 2023 Sep 30, 2022 | Q4 2022 Jun 30, 2022 | Q3 2022 Mar 31, 2022 | Q2 2022 Dec 31, 2021 | Q1 2022 Sep 30, 2021 | Q4 2021 Jun 30, 2021 | Q3 2021 Mar 31, 2021 | Q2 2021 Dec 31, 2020 | Q1 2021 Sep 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 438.06K | 417.22K | n/a | n/a | 6.15K | 572.83K | 599.19K | 490 | 504 | 509 | 526 | 523 | 506 | 438 |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -438.06K | -417.22K | n/a | n/a | -6.15K | -572.83K | -599.19K | -490 | -504 | -509 | -526 | -523 | -506 | -438 |
Operating Income | -3.46M | -6.4M | -3.65M | -4.67M | -3.65M | -53.13M | -213.38K | -290.79K | -259.9K | -420.87K | -438.06K | -417.22K | -209.6K | -386.21K | -608K | -572.83K | -599.19K | -502.18K | -403.47K | -486.03K | -726.94K | -427.95K | -274.09K | -383.16K |
Interest Income | 92 | 13 | 37 | 19 | 7 | 1 | n/a | 1 | n/a | 27 | 16 | 17 | 9 | 8 | 17 | 2 | 5.61K | n/a | n/a | n/a | n/a | n/a | 1 | n/a |
Pretax Income | -4.57M | -6.36M | -3.09M | -4.84M | -4.07M | -54.07M | -430.18K | -354.31K | -358.82K | -526.98K | -713K | -350.87K | -746.85K | -811.53K | -614.74K | -617.3K | -904.49K | -462.47K | -855.44K | -490.66K | -780.16K | -530.02K | -403.64K | -425.55K |
Net Income | -4.57M | -6.36M | -3.09M | -4.84M | -4.07M | -54.07M | -430.18K | -354.31K | -358.58K | -526.7K | -584.38K | -350.87K | -748.04K | -809.81K | -485.42K | -617.3K | -904.77K | -462.69K | -799.98K | -490.66K | -779.02K | -417.74K | -403.64K | -425.55K |
Selling & General & Admin | 3.08M | 6.23M | 3.63M | 4.61M | 3.59M | 53.07M | 158.99K | 229.08K | 207.51K | 355.42K | n/a | n/a | 197.31K | 320.19K | 526.98K | n/a | n/a | 451.3K | 352.21K | 438.97K | 641.35K | 382.54K | 223.42K | 331.88K |
Research & Development | 375.66K | 169.66K | 19.96K | 60.2K | 53.52K | 54.1K | 54.39K | 61.71K | 52.39K | 65.45K | n/a | n/a | 5.7K | 66.02K | 74.88K | n/a | n/a | 50.4K | 50.75K | 46.55K | 85.06K | 44.89K | 50.17K | 50.85K |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 6.6K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 3.46M | 6.4M | 3.65M | 4.67M | 3.65M | 53.13M | 213.38K | 290.79K | 259.9K | 420.87K | n/a | n/a | 209.6K | 386.21K | 601.86K | n/a | n/a | 501.69K | 402.96K | 485.52K | 726.41K | 427.43K | 273.59K | 382.72K |
Interest Expense | 27.67K | 38.27K | 58.96K | 305.65K | 254.54K | 104.04K | 118.94K | 86.23K | 90K | 133.14K | 264.46K | 178.23K | 114.24K | 157.21K | 98.62K | 162.75K | 113.67K | 167.38K | 177.91K | 109.85K | 29.44K | 102.9K | 157.84K | 159.28K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 8.71K | 7.24K | n/a |
Cost & Expenses | 3.46M | 6.4M | 3.65M | 4.67M | 3.65M | 53.13M | 213.38K | 290.79K | 259.9K | 420.87K | 438.06K | 417.22K | 209.6K | 386.21K | 608K | 572.83K | 599.19K | 502.18K | 403.47K | 486.03K | 726.94K | 427.95K | 274.09K | 383.16K |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -237 | -275 | -128.62K | n/a | 1.2K | -1.72K | -129.32K | n/a | 273 | 213 | -55.46K | n/a | -1.14K | -112.28K | n/a | n/a |
Shares Outstanding (Basic) | 112.37K | 63.89K | 53.44K | 49.33K | 15.87K | 17.3K | 534 | 49 | 164.03 | 73 | 1.59 | 0.73 | 1.74M | 0.03 | 0.05 | 0.03 | 68.22M | 2.65K | 0 | 0 | 562 | 0 | 36 | 0 |
Shares Outstanding (Diluted) | 112.37K | 63.89K | 53.44K | 49.33K | 15.87K | 17.3K | 534 | 49 | 164.03 | 73 | 1.59 | 0.73 | 1.74M | 0.03 | 0.05 | 0.03 | 68.22M | 2.65K | 0 | 0 | 562 | 0 | 36 | 0 |
EPS (Basic) | -40.70 | -99.54 | -75.29 | -98.08 | -256.51 | -3.12K | -805.50 | -7.2K | -2.19K | -7.42K | -389.89K | -673.51K | -0.46 | -30.56M | -10.54M | -31.88M | -0.02 | -263.75 | -349.71M | -334.62M | -2.08K | -6.99B | -11.2K | -10.69B |
EPS (Diluted) | -40.70 | -99.54 | -75.29 | -98.08 | -256.51 | -3.12K | -805.50 | -7.2K | -2.19K | -7.42K | -389.89K | -673.51K | -0.46 | -30.56M | -10.54M | -31.88M | -0.02 | -263.75 | -349.71M | -334.62M | -2.08K | -6.99B | -11.2K | -10.69B |
EBITDA | -4.54M | -6.32M | -3.03M | -4.53M | -3.81M | -53.96M | -306.91K | -262.55K | -263.05K | -389.06K | -448.43K | -172.5K | -632.29K | -653.87K | -509.97K | -454.07K | -790.34K | -294.61K | -677.04K | -380.3K | -750.19K | -426.6K | -245.3K | -265.83K |
EBIT | -4.55M | -6.32M | -3.03M | -4.53M | -3.82M | -53.96M | -311.24K | -268.08K | -268.81K | -393.84K | -448.54K | -172.63K | -632.61K | -654.32K | -516.12K | -454.54K | -790.83K | -295.1K | -677.54K | -380.8K | -750.72K | -427.12K | -245.8K | -266.26K |
Depreciation & Amortization | 6.38K | 6.59K | 6.03K | 3.7K | 5.24K | 5.09K | 4.33K | 5.53K | 5.76K | 4.77K | 114 | 134 | 320 | 450 | 6.15K | 473 | 490 | 490 | 504 | 509 | 526 | 523 | 506 | 438 |
Add to Watchlist
Select watchlists to add or remove PPCB